Modulation of amyloid-β aggregation and toxicity by inosose stereoisomers

FEBS Journal

Volumn 275, Issue 8, 2008, Pages 1663-1674

  Nitz, Mark ^a   Fenili, Daniela ^b,c   Darabie, Audrey A ^b   Wu, Ling ^b   Cousins, Julian E ^b   McLaurin, Joanne ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aggregation; Alzheimer's disease; Amyloid; Fibrillogenesis; Inosose

Indexed keywords

AMYLOID BETA PROTEIN; INOSITOL; INOSITOL DERIVATIVE; INOSOSE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; FLUORESCENCE SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT; STEREOISOMERISM;

AMYLOID BETA-PROTEIN; ANIMALS; BIOLOGICAL TRANSPORT; CELL SURVIVAL; CIRCULAR DICHROISM; INOSITOL; MICROSCOPY, ELECTRON; MOLECULAR STRUCTURE; PC12 CELLS; RATS; STEREOISOMERISM; SYMPORTERS;

EID: 41549105851     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06321.x     Document Type: Article

References (28)

1. Fisher SK, Novak JE Agranoff BW (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82, 736 754.
2. McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MHL, Phinney AL, Darabie AA, Cousins JE, French JE, Lan MF et al. (2006) Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med 12, 801 808.
3. Fenili D, Brown ME, Rappaport RV McLaurin J (2007) Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology. J Mol Med 85, 603 611.
4. McLaurin J, Franklin T, Chakrabartty A Fraser PE (1998) Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest. J Mol Biol 278, 183 194.
5. McLaurin J, Goloumb R, Jurewicz A, Antel JP Fraser PE (2000) Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit Aβ-induced toxicity. J Biol Chem 275, 18495 18502.
6. Chishti MA, Yang D, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J et al. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein. J Biol Chem 276, 21562 21570.
7. Townsend M, Cleary JP, Mehtra T, Hofmeister J, Lesne S, O'Hare E, Walsh DM Selkoe DJ (2006) Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-oligomers. Ann Neurol 60, 668 676.
8. Necula M, Kayed R, Milton S Glabe CG (2007) Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282, 10311 10324.
9. McLaurin J Fraser PE (2000) Effect of amino acid substitutions in Aβ1-28 on fibril formation and glycosaminoglycan interactions. Eur J Biochem 267, 6353 6361.
10. Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Ohashi R, Takegoshi K, Nagao M, Shimizu T Shirasawa T (2005) Structure of β-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease. J Biosci Bioeng 99, 437 447.
11. Spector R (1988) Myo-inositol transport through the blood-brain barrier. Neurochem Res 13, 785 787.
12. Wiesinger H (1991) Myo-inositol transport in mouse astroglia-rich primary cultures. J Neurochem 56, 1698 1704.
13. Rubin LJ Hale CC (1993) Characterization of a Mg-dependent, Na-inositol co-transport process in cardiac sarcolemmal vesicles. J Mol Cell Cardiol 25, 721 731.
14. Uldry M, Ibberson M, Horisberger J-D, Chatton J-Y, Riederer BM Thorens B (2001) Identification of a mammalian H-myo-inositol symporter expressed predominantly in the brain. EMBO J 20, 4467 4477.
15. Coady MJ, Wallendorff B, Gagnon DG Lapointe J-Y (2002) Identification of a novel Na+/myo-inositol cotransporter. J Biol Chem 277, 35219 35224.
16. Isaacks RE, Bender AS, Kim CY Norenberg MD (1997) Effect of osmolality and myo-inositol deprivation on the transport properties of myo-inositol in primary astrocyte cultures. Neurochem Res 22, 1461 1469.
17. Hager K, Hazama A, Kwon HM, Loo DD, Handler JS Wright EM (1995) Kinetics and specificity of the renal Na+/myo-inositol cotransporter expressed in Xenopus oocytes. J Membr Biol 143, 103 113.
18. Palmano KP, Whiting PH Hawthorne JN (1977) Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes. Biochem J 167, 229 235.
19. Lorenzo A Yankner B (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc Natl Acad Sci USA 91, 12243 12247.
20. Porat Y, Abramowitz A Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67, 27 37.
21. Fraser PE, Darabie AA McLaurin J (2001) Amyloid-b interactions with chondroitin sulfate-derived monosaccharides and disaccharides. Implications for drug development. J Biol Chem 276, 6412 6419.
22. Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M Hasegawa M. (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280, 7614 7623.
23. Pickhardt M, von Bergen M, Gazova Z, Hascher A, Biernat J, Mandelkow EM Mandelkow E. (2005) Screening for inhibitors of tau polymerization. Curr Alzheimer Res 2, 219 226.
24. Howlett DR, George AR, Owen DE, Ward RV Markwell RE. (1993) Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer. Biochem J 343, 419 423.
25. Lashuel HA, Hartley DM, Balakhaneh D, Aggarwal A, Teichberg S Callaway DJE (2002) New class of inhibitors of amyloid-β fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease. J Biol Chem 277, 42881 42890.
26. Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14, 611 650.
27. Spector R (1978) The transport and metabolism of scyllo-inositol in the central nervous system. J Neurochem 31, 1113 1115.
28. Jao S, Ma K, Talafous J, Orlando R Zagorski MG (1997) Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide. Amyloid Int J Exp Clin Invest 4, 240 252.